<?xml version="1.0" encoding="UTF-8"?>
<ref id="B62-ijms-21-05559">
 <label>62.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Premkumar</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Segovia-Chumbez</surname>
    <given-names>B.</given-names>
   </name>
   <name>
    <surname>Jadi</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Martinez</surname>
    <given-names>D.R.</given-names>
   </name>
   <name>
    <surname>Raut</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Markmann</surname>
    <given-names>A.J.</given-names>
   </name>
   <name>
    <surname>Cornaby</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Bartelt</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Weiss</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Park</surname>
    <given-names>Y.</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients</article-title>
  <source>Sci. Immunol.</source>
  <year>2020</year>
  <volume>5</volume>
  <fpage>eabc8413</fpage>
  <pub-id pub-id-type="doi">10.1126/sciimmunol.abc8413</pub-id>
  <pub-id pub-id-type="pmid">32527802</pub-id>
 </element-citation>
</ref>
